Sex and time trends in cardiovascular disease incidence and mortality: The Framingham Heart Study, 1950-1989

American Journal of Epidemiology

Volumn 143, Issue 4, 1996, Pages 338-350

  Sytkowski, Pamela A ^a,b,d   D'Agostino, Ralph B ^a,b   Belanger, Albert ^a,b   Kannel, William B ^a,c  

^a FRAMINGHAM HEART STUDY   (United States)

^b Boston University   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BOSTON UNIVERSITY   (United States)

Author keywords

cardiovascular diseases; incidence; mortality; risk factors; sex

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; FEMALE; HEALTH SURVEY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RISK; RISK FACTOR; SEX DIFFERENCE;

CARDIOVASCULAR DISEASE; DISEASE INCIDENCE; MORTALITY TREND; SEX DIFFERENCE; TEMPORAL VARIATION;

USA, MASSACHUSETTS, FRAMINGHAM;

EID: 0029669706     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a008748     Document Type: Article

References (40)

1. Klag MJ, Whelton PK, Seidler AJ. Decline in US stroke mortality: demographic trends and antihypertensive treatment. Stroke 1989;20:14-21.
2. Ragland KE, Selvin S, Merrill DW. The onset of decline in ischemic heart disease mortality in the United States. Am J Epidemiol 1988;127:516-31.
3. Davis WB, Hayes CG, Knowles M, et al. Geographic variation in declining ischemic heart disease mortality in the United States, 1968-1978. I. Rates and change, whites ages 35-74 years. Am J Epidemiol 1985;122:657-72.
4. Wing S, Hayes C, Heiss G. et al. Geographic variation in the onset of decline of ischemic heart disease mortality in the United States. Am J Public Health 1986;76:1404-8.
5. Cooper R, Stamler J, Dyer A, et al. The decline in mortality from coronary heart disease, USA, 1968-1975. J Chronic Dis 1978;31:709-20.
6. Sytkowski PA, Kannel WB, D'Agostino RB. Changes in risk factors and the decline in mortality from cardiovascular disease: the Framingham Heart Study. N Engl J Med 1990; 322:1635-41.
7. Dawber TR. The Framingham Study: the epidemiology of atherosclerotic disease. Cambridge, MA: Harvard University Press, 1980.
8. Belanger A, Cupples A, D'Agostino RB. Means at each examination and inter-examination variation of specified characteristics: Framingham Heart Study, 30-year follow-up. In: Kannel WB, Wolf PA, Garrison RJ, eds. The Framingham Study: an epidemiological investigation of cardiovascular disease. Sect 36. Washington, DC: GPO, 1988. (NIH publication no. 88-2970; NTIS PB88-200050).
9. D'Agostino RB, Kannel WB. Epidemiological background and design: the Framingham Study. In: Gail MH, Johnson NL, eds. Sesquicentennial invited paper session. Proceedings of the American Statistical Association sesquicentennial 1988-89. Alexandria, VA: American Statistical Association, 1989:707-18.
10. Cupples LA, D'Agostino RB. Some risk factors related to the annual incidence of cardiovascular disease and death using pooled repeated biennial measurements: Framingham Study, 30-year follow-up. In: Kannel WB, Wolf PA, Garrison RJ, eds. The Framingham Study: an epidemiological investigation of cardiovascular disease. Sect 34. Washington, DC: GPO, 1987. (NIH publication no. 87-2703; NTIS PB87-177499).
11. National Institutes of Health Consensus Development Panel on the Health Implications of Obesity. Health implications of obesity: National Institutes of Health consensus development conference statement. Ann Intern Med 1985;103:1073-7.
12. Laboratory Methods Committee of the Lipid Research Clinics Program of the National Heart, Lung, and Blood Institute. Cholesterol and triglyceride concentration in serum/plasma pairs. Clin Chem 1977;23:60-3.
13. Feinleib M, Garrison RJ, Stallones L, et al. A comparison of blood pressure, total cholesterol, and cigarette smoking in parents in 1950 and their children in 1970. Am J Epidemiol 1979;110:291-303.
14. Searle SR. Linear models. New York: John Wiley & Sons, Inc. 1971.
15. SAS Institute, Inc. SAS user's guide, version 5 ed. Cary, NC: SAS Institute, Inc, 1985.
16. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic research: principles and quantitative methods. New York: Van Nostrand Reinhold Company, 1982.
17. Lawless JF. Statistical models and methods for lifetable data. New York: John Wiley & Sons, Inc, 1982.
18. Leaverton PE, Sorlie PD, Kleinman JC, et al. Representativeness of the Framingham risk model for coronary heart disease mortality: a comparison with a national cohort study. J Chronic Dis 1987;40:775-84.
19. Kannel WB, Sytkowski PA. Risk factors for atherosclerotic disease. Pharmacol Ther 1987;32:207-35.
20. Pell S, Fayerweather WE. Trends in the incidence of myocardial infarction and in associated mortality and morbidity in a large employed population, 1957-1983. N Engl J Med 1985; 312:1005-11.
21. Elveback L, Connolly DC, Melton LJ III. Coronary heart disease in residents of Rochester, Minnesota. VII. Incidence, 1950 through 1982. Mayo Clin Proc 1986;61:896-900.
22. Goldberg RJ, Gore JM, Alpen JS, et al. Recent changes in attack and survival rates of acute myocardial infarction (1975 through 1982): the Worcester Heart Attack Study. JAMA 1986;255:2774-9.
23. Goldberg RJ, Gore JM, Alpert JS, et al. Incidence and case fatality rates of acute myocardial infarction (1975-1984): the Worcester Heart Attack Study. Am Heart J 1988;115:761-7.
24. Wolf PA, D'Agostino RB, O'Neal A, et al. Secular trends in stroke incidence and mortality. The Framinaham Study. Stroke 1992;23:1551-5.
25. Sobel BE, Jaffe AS. The value and limitations of cardiac enzymes in the recognition of acute myocardial infarction. Heart Dis Stroke 1993;2:26-32.
26. Clarke KW, Gray D, Keating NA, et al. Do women with acute myocardial infarction receive the same treatment as men? BMJ 1994;309:563-6.
27. Gomez-Marin O, Folsom AR, Kottke TE. et al. Improvement in long-term survival among patients hospitalized with acute myocardial infarction, 1970 to 1980: the Minnesota Heart Survey. N Engl J Med 1987;316:1353-9.
28. Sytkowski PA. Declining mortality from cardiovascular disease. Compr Ther 1991;17:39-44.
29. Manton KG. Changing concepts of morbidity and mortality in the elderly population. Milbank Mem Fund Q Health Soc 1981;60:183-244.
30. Verbrugge LM. Longer life but worsening health? Trends in health and mortality of middle-aged and older persons. Milbank Mem Fund Q Health Soc 1984;62:475-519.
31. Department of Health and Human Services. Blood pressure levels in persons 18-74 years of age in 1976-1980, and trends in blood pressure from 1960 to 1980 in the United States. Hyattsville, MD: National Center for Health Statistics. 1972. (DHHS publication no. (PHS) 86-1684).
32. National Center for Health Statistics. National Heart. Lung, and Blood Institute Lipid Group. Trends in serum cholesterol levels among US adults aged 20 to 74 years. Data from the National Health and Nutrition Examination surveys, 1960 to 1980. JAMA 1987;257:937-42.
33. National Center for Health Statistics. Prevention profile: health, United States, 1986. Washington, DC: GPO, 1976: 125-6. (DHHS publication no. (PHS) 87-1232).
34. Johnson CL, Rifkind BM, Sempos CT, et al. Declining serum total cholesterol levels among US adults: the National Health and Nutrition Examination surveys. JAMA 1993;269:3002-8.
35. Sprafka JM, Burke GL, Folsom AR, et al. Continued decline in cardiovascular disease risk factors: results of the Minnesota Heart Survey, 1980-1982 and 1985-1987. Am J Epidemiol 1990;132:489-500.
36. Luepker RV, Murray DM, Jacobs DR, et al. Community education for cardiovascular disease prevention: risk factor changes in the Minnesota Heart Health Program. Am J Public Health 1994;84:1383-93.
37. Walker WJ. Changing United States life-style and declining vascular mortality: cause or coincidence? N Engl J Med 1977; 297:163-5.
38. Goldman L, Cook EF. The decline in ischemic heart disease mortality rates. An analysis of the comparative effects of medical interventions and changes in lifestyle. Ann Intern Med 1984;101:825-36.
39. Pearson TA. Determinants of coronary heart disease mortality. In: Higgins MW, Luepker RV, eds. Trends in coronary heart disease mortality: the influence of medical care. New York: Oxford University Press, 1988:94-8.
40. Kaplan GA, Cohn BA, Cohen RD, et al. The decline in ischemic heart disease mortality: prospective evidence from the Alameda County Study. Am J Epidemiol 1988;127: 1131-42.